In this Issue:
Clinicopathological characteristics of BRAF K601E and BRAF L597 mutations in melanoma
Patterns of melanoma recurrence following a negative SNB
Adjuvant and salvage radiotherapy for desmoplastic melanoma
Prognostic score for patients with advanced melanoma treated with ipilimumab
Survival of patients with advanced metastatic melanoma treated with novel therapies
Sunitinib treatment in patients with metastatic mucosal or acral melanoma
Acquired BRAF inhibitor resistance
Treatment of BRAF V600-mutant metastatic melanoma with dabrafenib + trametinib
Nab-paclitaxel vs dacarbazine in chemotherapy-naïve patients with metastatic melanoma
Melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy
Please login below to download this issue (PDF)